Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) LOC100130100///LOC652694///LOC652493///LOC650405///IGKV1-5///IGKC → LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC100133862///IGHM → LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) IGKC → LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → RPS8P10///RPS8 (>>) |
| LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → SMAD6 (>>) |
| LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → GUCY2D (>>) |
